EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

COX5A Alleviates Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress, Mitochondrial Dysfunction and Cardiomyocyte Apoptosis

Peipei Zhang, Hao Lu, Yuan Wu, Danbo Lu iD, Chenguang Li, Xiangdong Yang, Zhangwei Chen, Juying Qian, Junbo Ge

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241210400 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Peipei Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for …. Hauptthemen laut MEDLINE: Cardiomyopathies, Cardiotoxicity, Doxorubicin, Electron Transport Complex IV. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Program on Key Basic Research Project of China, Shanghai Clinical Research Center for Interventional Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doxorubicin (DOX) as a chemotherapeutic agent can cause mitochondrial dysfunction and heart failure. COX5A has been described as an important regulator of mitochondrial energy metabolism. We investigate the roles of COX5A in DOX-induced cardiomyopathy and explore the underlying mechanisms. C57BL/6J mice and H9c2 cardiomyoblasts were treated with DOX, and the COX5A expression was assessed. An adeno-associated virus serum type 9 (AAV9) and lenti-virus system were used to upregulate COX5A expression. Echocardiographic parameters, morphological and histological analyses, transmission electron microscope and immunofluorescence assays were used to assess cardiac and mitochondrial function. In a human study, we found that cardiac COX5A expression was dramatically decreased in patients with end-stage dilated cardiomyopathy (DCM) compared to the control group. COX5A was significantly downregulated following DOX stimulation in the heart of mice and H9c2 cells. Reduced cardiac function, decreased myocardium glucose uptake, mitochondrial morphology disturbance, reduced activity of mitochondrial cytochrome c oxidase (COX) and lowered ATP content were detected after DOX stimulation in mice, which could be significantly improved by overexpression of COX5A. Overexpression of COX5A effectively protected against DOX-induced oxidative stress, mitochondrial dysfunction and cardiomyocyte apoptosis in vivo and in vitro. Mechanistically, the phosphorylation of Akt (Thr308) and Akt (Ser473) were also decreased following DOX treatment, which could be reserved by the upregulation of COX5A. Furthermore, PI3K inhibitors abrogated the protection effects of COX5A against DOX-induced cardiotoxicity in H9c2 cells. Thus, we identified that PI3K/Akt signaling was responsible for the COX5A-mediated protective role in DOX-induced cardiomyopathy. These results demonstrated the protective effect of COX5A in mitochondrial dysfunction, oxidative stress, and cardiomyocyte apoptosis, providing a potential therapeutic target in DOX-induced cardiomyopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomyopathiesCardiotoxicityDoxorubicinElectron Transport Complex IVAnimalsHumansMiceApoptosisMice, Inbred C57BLMitochondriaMyocytes, CardiacOxidative StressPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt

Stichwörter der Autor:innen

COX5Aapoptosisdoxorubicinmitochondrial dysfunctionoxidative stress

Substanzen

COX5A protein, humanDoxorubicinElectron Transport Complex IVPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai 200032, China.

ORCID-Profile: Danbo Lu

Förderung

  • National Natural Science Foundation of China
  • National Program on Key Basic Research Project of China
  • Shanghai Clinical Research Center for Interventional Medicine
  • Shanghai Shenkang on Key Clinical Research Project
  • Shanghai Science and Technology Committee
  • Key Medical and Health Projects of Xiamen Province
  • Zhongshan Hospital Affiliated to Fudan University

Zitieren

APA

Zhang, P., Lu, H., Wu, Y., Lu, D., Li, C., Yang, X., Chen, Z., Qian, J., & Ge, J. (2023). COX5A Alleviates Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress, Mitochondrial Dysfunction and Cardiomyocyte Apoptosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241210400

Vancouver

Zhang P, Lu H, Wu Y, Lu D, Li C, Yang X, et al. COX5A Alleviates Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress, Mitochondrial Dysfunction and Cardiomyocyte Apoptosis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241210400

BibTeX
@article{Zhang2023,
  author = {Zhang, Peipei and Lu, Hao and Wu, Yuan and Lu, Danbo and Li, Chenguang and Yang, Xiangdong and Chen, Zhangwei and Qian, Juying and Ge, Junbo},
  title = {COX5A Alleviates Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress, Mitochondrial Dysfunction and Cardiomyocyte Apoptosis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241210400}
}
Kostenlos starten →